To combat these difficulties, near sixty scientists, led by researchers at the Sanford Burnham Prebys Medical Discovery Institute, teamed-up for ALG1-CDG and published a study online on March 2 in the prestigious journal Human Mutation (1). ALG1-CDG (MIM #608540, CDG-Ik according to previous nomenclature) is a type of congenital disorders of glycosylation (CDG) with a broad clinical spectrum (please read reliable information about CDG HERE).
|